APA

Lasser R. A., Dirks B., Nasrallah H., Kirsch C., Gao J., Pucci M. L., Knesevich M. A. & Lindenmayer J. (20140505). Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. : Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Chicago

Lasser Robert A, Dirks Bryan, Nasrallah Henry, Kirsch Courtney, Gao Joseph, Pucci Michael L, Knesevich Mary A and Lindenmayer Jean-Pierre. 20140505. Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. : Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Harvard

Lasser R. A., Dirks B., Nasrallah H., Kirsch C., Gao J., Pucci M. L., Knesevich M. A. and Lindenmayer J. (20140505). Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. : Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

MLA

Lasser Robert A, Dirks Bryan, Nasrallah Henry, Kirsch Courtney, Gao Joseph, Pucci Michael L, Knesevich Mary A and Lindenmayer Jean-Pierre. Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. : Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 20140505.